576 related articles for article (PubMed ID: 24413778)
41. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications.
Walther MM; Lubensky IA; Venzon D; Zbar B; Linehan WM
J Urol; 1995 Dec; 154(6):2010-4; discussion 2014-5. PubMed ID: 7500446
[TBL] [Abstract][Full Text] [Related]
42. [Malignant pheochromocytoma combined with multiple renal cell carcinomas and a renal cyst. Indication for von Hippel-Lindau syndrome?].
Hofmockel G; Manseck A
Dtsch Med Wochenschr; 2000 Jun; 125(24):767-8. PubMed ID: 10902516
[No Abstract] [Full Text] [Related]
43. von Hippel-Lindau Disease: Review of Genetics and Imaging.
Shanbhogue KP; Hoch M; Fatterpaker G; Chandarana H
Radiol Clin North Am; 2016 May; 54(3):409-22. PubMed ID: 27153780
[TBL] [Abstract][Full Text] [Related]
44. von Hippel-Lindau disease: radiologic screening for visceral manifestations.
Choyke PL; Filling-Katz MR; Shawker TH; Gorin MB; Travis WD; Chang R; Seizinger BR; Dwyer AJ; Linehan WM
Radiology; 1990 Mar; 174(3 Pt 1):815-20. PubMed ID: 2305064
[TBL] [Abstract][Full Text] [Related]
45. Neuroendocrine tumor of the pancreas and bilateral adrenal pheochromocytomas. A rare manifestation of von Hippel-Lindau disease in childhood.
Langrehr JM; Bahra M; Kristiansen G; Neumann HP; Neumann LM; Plöckinger U; Lopez-Hänninen E
J Pediatr Surg; 2007 Jul; 42(7):1291-4. PubMed ID: 17618900
[TBL] [Abstract][Full Text] [Related]
46. Hepatobiliary and Pancreatic: Pancreatic mixed serous neuroendocrine neoplasm in von Hippel-Lindau disease.
Yamashima M; Ozawa E; Ohnita K; Tabata K; Natsuda K; Ono S; Hidaka M; Eguchi S; Nakao K
J Gastroenterol Hepatol; 2018 Nov; 33(11):1821. PubMed ID: 29888404
[No Abstract] [Full Text] [Related]
47. von Hippel-Lindau syndrome.
Chou A; Toon C; Pickett J; Gill AJ
Front Horm Res; 2013; 41():30-49. PubMed ID: 23652669
[TBL] [Abstract][Full Text] [Related]
48. von Hippel-Lindau disease: epididymal cystadenoma targeted by metastatic events.
Mehta GU; Shively SB; Gläsker S; Bechert CJ; Zhuang Z; Raffeld M; Lonser RR; Oldfield EH; Vortmeyer AO
Urology; 2007 Jun; 69(6):1209.e9-12. PubMed ID: 17572225
[TBL] [Abstract][Full Text] [Related]
49. VHL-gene deletion in single renal tubular epithelial cells and renal tubular cysts: further evidence for a cyst-dependent progression pathway of clear cell renal carcinoma in von Hippel-Lindau disease.
Montani M; Heinimann K; von Teichman A; Rudolph T; Perren A; Moch H
Am J Surg Pathol; 2010 Jun; 34(6):806-15. PubMed ID: 20431476
[TBL] [Abstract][Full Text] [Related]
50. Pancreatic lesions in von Hippel-Lindau disease.
Mukhopadhyay B; Sahdev A; Monson JP; Besser GM; Reznek RH; Chew SL
Clin Endocrinol (Oxf); 2002 Nov; 57(5):603-8. PubMed ID: 12390333
[TBL] [Abstract][Full Text] [Related]
51. [Pheochromocytoma, first manifestation of Von Hippel-Lindau disease: a possibility to be considered].
Richard S; Resche F; Vermesse B; Fendler JP; Francillard M; Laroche F; Luton JP; Méry JP; Proye C; Redondo A
Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1153-6. PubMed ID: 1482250
[TBL] [Abstract][Full Text] [Related]
52. CT screening of the abdomen in von Hippel-Lindau disease.
Levine E; Collins DL; Horton WA; Schimke RN
AJR Am J Roentgenol; 1982 Sep; 139(3):505-10. PubMed ID: 6981314
[TBL] [Abstract][Full Text] [Related]
53. [Von Hippel-Lindau disease type 2-related pancreatic neuroendocrine tumor and adrenal myelolipoma].
Dolzhansky OV; Morozova MM; Korostelev SA; Kanivets IV; Chardarov NK; Shatveryan GA; Paltseva EM; Fedorov DN
Arkh Patol; 2016; 78(1):36-41. PubMed ID: 26978235
[TBL] [Abstract][Full Text] [Related]
54. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
[TBL] [Abstract][Full Text] [Related]
55. Diagnosis and management of pancreatic neuroendocrine tumor in von Hippel-Lindau disease.
Tamura K; Nishimori I; Ito T; Yamasaki I; Igarashi H; Shuin T
World J Gastroenterol; 2010 Sep; 16(36):4515-8. PubMed ID: 20857520
[TBL] [Abstract][Full Text] [Related]
56. [Gastroenterological manifestations of von Hippel-Lindau disease - a case report].
Koniusz J; Dąbkowski K; Buczek K; Gomółka A; Starzyńska T
Pol Merkur Lekarski; 2017 Aug; 43(254):66-68. PubMed ID: 28875972
[TBL] [Abstract][Full Text] [Related]
57. New von Hippel-Lindau manifestations develop at the same or decreased rates in pregnancy.
Binderup ML; Budtz-Jørgensen E; Bisgaard ML
Neurology; 2015 Oct; 85(17):1500-3. PubMed ID: 26408493
[TBL] [Abstract][Full Text] [Related]
58. Clear cell neuroendocrine tumor of the pancreas in von Hippel-Lindau disease: a case report and literature review.
Woo CG; Choi SY; Kwak JJ; Chin S; Kim HK
Neuro Endocrinol Lett; 2017 May; 38(2):83-86. PubMed ID: 28650600
[TBL] [Abstract][Full Text] [Related]
59. Pancreatic lesions in von Hippel-Lindau syndrome: report of a case.
Künzli BM; Shrikhande SV; Büchler MW; Friess H
Surg Today; 2004; 34(7):626-9. PubMed ID: 15221562
[TBL] [Abstract][Full Text] [Related]
60. The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients.
Choyke PL; Glenn GM; Walther MM; Zbar B; Weiss GH; Alexander RB; Hayes WS; Long JP; Thakore KN; Linehan WM
AJR Am J Roentgenol; 1992 Dec; 159(6):1229-34. PubMed ID: 1442389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
